跳至主要内容
临床试验/NCT06377280
NCT06377280已完成不适用

An Un-controlled, Prospective, Multi-center, Post Market Clinical Follow-up Investigation to Confirm Performance and Safety of Navina Mini, a New CE-marked Low-volume Transanal Irrigation (TAI) Device.

Wellspect HealthCare1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2024年1月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
1
主要终点
Patient satisfaction

研究概览

简要总结

This is an un-controlled, prospective, multi center, post market clinical follow-up investigation that will enroll male and female subjects in need of bowel management with low-volume transanal irrigation (TAI) as judged by the investigator. A total of 40 investigational subjects in need of low-volume TAI will be recruited from 2-3 sites in Sweden and will be treated with Navina Mini as per product intended purpose and per instruction of use during a period of four weeks.

Participating subjects will perform three visits during the clinical investigation and will be followed for a total of four weeks. The first visit, Visit 1, will be performed at the investigational clinic to assess eligibility, collect demographics, baseline data and instruct how to use the device. Visit 2 will be performed after two weeks of treatment through telephone contact. The final visit, Visit 3, will be performed after additional two weeks of treatment, and can be performed either at the investigational clinic or through telephone contact.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • Anal incontinence or faecal outlet problems without any pathological obstruction in the ano-rectum.
  • Symptom duration of > 6 months
  • Adult male and females >18 years old
  • Patient can communicate in written and oral Swedish language

排除标准

  • Subjects treated with high volume TAI i.e., volume > 250 ml
  • Pregnancy at the time of enrollment
  • Participating in another clinical investigation interfering with this investigation
  • Subjects with active, symptomatic inflammatory bowel disease, radiation proctitis and or active perianal fistula disease
  • Rectal bleeding of uncertain origin or active hemorrhoidal bleeding
  • < 6 months after anal or colorectal surgery
  • Ongoing anti-coagulant therapy (eg. NOACS, heparin, Warfarin)
  • Acute diverticulitis and diverticular abscess
  • Ischemic colitis
  • Colorectal cancer
  • Any physical handicap that prevents usage of product
  • Inability to use product or anyone to assist in its usage
  • Person not suitable for the investigation according to the investigator judgement

结局指标

主要结局

Patient satisfaction

时间窗: 4 weeks

Patient Reported Outcome - Overall patient satisfaction when performing low- volume trans-anal irrigation measured with a 5-graded scale \[0 = Not at all satisfied, 1 = Not satisfied, 2 = Neither satisfied nor unsatisfied, 3=Satisfied, 4 = Very satisfied\]

次要结局

  • Ease of handling(4 weeks)
  • Safety Outcome(4 weeks)
  • Assessment of clinical benefit(4 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验